Article Processing Charges (APC)

Journal of Drug Delivery and Biotherapeutics is committed to making all of its research articles accessible to a wide audience by publishing them in full open access. This means that our articles are freely available for unlimited use and reuse, with proper credit given to the authors. All articles are published under a Creative Commons (CC BY) license.

Why APC?

To sustain the high-quality publishing services we provide, authors are required to pay a one-time Article Processing Charge (APC). The APC covers several essential aspects of the publication process, including:

  • Peer review administration and management: Ensuring rigorous and constructive peer review.
  • Professional production of articles: Preparing articles in various formats, including PDF.
  • Dissemination: Making published papers available through multiple channels.
  • Publishing functions: Supporting various aspects of journal management.

Please note that payment of the APC does not guarantee manuscript acceptance. However, there are no charges for articles that are rejected, no submission charges, and no additional charges based on article length, figures, or supplementary data. Certain types of content, such as Editorials, Corrections, Addendums, Retractions, Comments, etc., are published free of charge.

Open Access at a Glance

All articles published in "Journal of Drug Delivery and Biotherapeutics" (ISSN xxxx-xxxx) are published in full open access.

An article processing charge (APC) of 2500/- INR applies to papers that have been accepted after peer review.

Local VAT or Sales Tax may be added if applicable.

Special Offer: No APC until December 2023

We are pleased to announce that "Journal of Drug Delivery and Biotherapeutics" is waiving the complete Article Processing Charges until December 2023. This means that all articles accepted for publication will be published free of cost during this period.

By offering this special promotion, we aim to facilitate the dissemination of valuable research and support the global academic community in accessing and sharing knowledge. We encourage authors to take advantage of this opportunity to contribute to our journal and make their research widely accessible.

For more information or specific inquiries regarding APCs, please refer to our journal's website or contact our editorial team.

Thank you for considering "Journal of Drug Delivery and Biotherapeutics" for your research contributions. We look forward to receiving your valuable submissions and contributing to the advancement of scientific knowledge.